Literature DB >> 910267

Chronic liver dysfunction in multitransfused hemophiliacs.

U W Hasiba, J A Spero, J H Lewis.   

Abstract

Liver dysfunction and exposure to the hepatitis B antigen were assessed by serum transaminase (SGPT and SGOT) levels and HBsAg and anti-HBs during a three year period in a group of 118 patients with factor VIII or factor IX deficiency. The 107 HBsAg negative patients were divided into four groups according to their mode of therapy. Persistently abnormal transaminase values were present in 51 per cent of patients with a large exposure to factor VIII concentrates, in 43 per cent with a small factor VIII exposure and in 37 per cent exposed to prothrombin complexes. This was contrasted with abnormalities in 8 per cent of patients treated only with cryoprecipitate. The incidence and degree of serum transaminase abnormality appeared independent of a past history of jaundice. All patients without persistent antigenemia who had been treated with pooled plasma products showed antibodies to HBsAg. High titer anti-HBs prior to initial fraction therapy appeared protective against jaundice. The eleven patients with persistent antigenemia had significantly higher transaminase levels than the HBsAg negative group.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 910267     DOI: 10.1046/j.1537-2995.1977.17578014589.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Cost without benefit? The introduction of hepatitis B vaccine in Canada.

Authors:  R A Coates; J G Rankin
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262

2.  Liver function in Edinburgh haemophiliacs: a five-year follow-up.

Authors:  M L Stirling; G J Beckett; I W Percy-Robb
Journal:  J Clin Pathol       Date:  1981-01       Impact factor: 3.411

3.  Viral exposure and abnormal liver function in haemophilia.

Authors:  B A McVerry; M G Ross; W A Knowles; J Voke
Journal:  J Clin Pathol       Date:  1979-04       Impact factor: 3.411

4.  Management of Haemophilia in Developing Countries: Challenges and Options.

Authors:  Kanjaksha Ghosh; Kinjalka Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2015-06-18       Impact factor: 0.900

5.  Liver dysfunction in Pennsylvania's multitransfused hemophiliacs.

Authors:  U Hasiba; M E Eyster; F M Gill; M Kajani; J H Lewis; C J Lusch; D Prager; S A Rice; S S Shapiro
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.